Poulton Stuart
- SEC CIK
- 0001942597
In the past year, 4 open-market sale filings worth $56.4K and no purchases.
Current role at each company
- KPTI Karyopharm Therapeutics Inc.EVP, Chief Development Officeras of Jul 30, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $56.4K
- 4 filings
- Net
- −$56.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Poulton Stuart as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 (view filing)4:42 PM ET | Jul 28 | 2 days | Poulton StuartEVP, Chief Development Officer | SSale | −189 | $7.10 | −$1.34K | −0.2%94.6K after | |
| May 15, 2026 (view filing) | May 14 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −403 | $9.50 | −$3.83K | −0.4%94.8K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −5.10K | $9.41 | −$48.0K | −5.1%94.3K after | |
| Feb 19, 2026 (view filing) | Feb 17 | 2 days | Poulton StuartEVP, Chief Development Officer | SSale | −378 | $8.63 | −$3.26K | −0.4%99.4K after | |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −401 | $6.43 | −$2.58K | −1.4%27.7K after | |
| Jul 30, 2025 (view filing) | Jul 29 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −191 | $4.37 | −$834.67 | −0.7%27.2K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Poulton StuartEVP, Chief Development Officer | SSale | −3.55K | $6.29 | −$22.3K | −11.5%27.4K after | |
| Feb 19, 2025 (view filing) | Feb 18 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −5.91K | $0.63 | −$3.73K | −1.8%320.7K after | |
| Jul 31, 2024 (view filing) | Jul 30 | 1 day | Poulton StuartEVP, Chief Development Officer | SSale | −2.88K | $1.06 | −$3.06K | −0.9%326.6K after | |
| Mar 4, 2024 (view filing) | Feb 29-Mar 1 | 4 days | Poulton StuartEVP, Chief Development Officer | SSaleCommon | −22.5K | $1.18 | −$26.5K | −6.4%329.5K after | 2 lots |
| Feb 20, 2024 (view filing) | Feb 15 | 5 days | Poulton StuartEVP, Chief Development Officer | SSale | −5.85K | $1.33 | −$7.78K | −3.4%163.8K after | 2 lots |
| Aug 1, 2023 (view filing) | Jul 28 | 4 days | Poulton StuartEVP, Chief Development Officer | SSale | −2.85K | $1.70 | −$4.84K | −1.8%156.3K after | 10b5-1 |
| Feb 17, 2023 (view filing) | Feb 15 | 2 days | Poulton StuartEVP, Chief Development Officer | SSale | −5.87K | $3.19 | −$18.7K | −8.4%64.1K after | 3 lots |